The German edition of WIRED talked to Dr. Martin Kampmann about his research, and his future plans for working with the Chan Zuckerberg Biohub. Read the interview here.
Dr. Martin Kampmann was named a Chan Zuckerberg Biohub Investigator. He is part of the first cohort of 47 scientists from UCSF, Stanford and Berkeley to join the Biohub.
The National Institute of Neurological Disorders and Stroke (NINDS), part of the NIH, established a new multidisciplinary "Center Without Walls" for research on Tau, a protein involved in Alzheimer's Disease, Frontotemporal Degeneration and other neurodegenerative diseases.
The Kampmann Lab's approach of using CRISPR to identify relevant genes, mechanisms, and therapeutic targets in neurodegenerative diseases such as Alzheimer's Disease and Parkinson's Disease was featured today in a
HIV can withstand therapy in a "latent state" in patient cells. Understanding what controls latency may be the basis for an HIV cure. In collaboration with Eric Verdin's lab at the Gladstone institute, we conducted a genome-wide screen for factors in human cells that control HIV latency. We found…
Postdoctoral Fellow John Chen in the Kampmann lab received a Research Fellowship from the Alzheimer's Association. Together with Diane Nathaniel, John investigates cellular pathways controlling the prion-like spread of tau aggregation, which is emerging as a key driver of disease progression in…
Dr. John Chen, postdoctoral fellow in the Kampmann lab, won a QB3/Calico Longevity Fellowship. John works with Diane Nathaniel in the lab to uncover cellular pathways controlling aggregation and prion-like spread of the protein tau, which is associated with Alzheimer’s Disease, frontotemporal…
Stand Up To Cancer announced at the 2016 Annual Meeting of the American Association for Cancer Research that it is awarding 10 grants of $750,000 each to early-career scientists to support innovative, high-risk, high-reward projects in cancer research. Dr. Martin Kampmann was one of…
Stephanie See (graduate student, Chemistry & Chemical Biology Program) was awarded the National Defense Science & Engineering Graduate (NDSEG) Fellowship. Stephanie's research is focused on the cellular mechanisms controlling the aggregation of spread of alpha-synuclein, which is associated…
This morning, the National Institutes of Health (NIH) announced a New Innovator Award for Dr. Martin Kampmann. This $1.5 million award is part of the High-Risk, High-Reward Research program established by the NIH to support exceptionally innovative biomedical research. The Kampmann lab investigates…
